Nanovibronix, Inc. (NASDAQ:FEED) Sees Significant Growth in Short Interest

Nanovibronix, Inc. (NASDAQ:FEED) saw a large increase in short interest in June. As of June 15th, there was short interest totaling 409,683 shares, an increase of 546.8% from the May 31st total of 63,342 shares. Based on an average daily volume of 2,865,952 shares, the short-interest ratio is presently 0.1 days. Currently, 6.8% of the shares of the stock are short sold.

Nanovibronix Stock Performance

NASDAQ FEED traded up $0.01 during mid-day trading on Friday, reaching $0.58. 53,687 shares of the stock were exchanged, compared to its average volume of 6,852,107. The company has a 50 day moving average of $1.03. Nanovibronix has a one year low of $0.55 and a one year high of $17.40. The stock has a market cap of $3.54 million, a PE ratio of -0.07 and a beta of 1.51.

Nanovibronix (NASDAQ:FEED) last announced its earnings results on Monday, May 18th. The company reported ($6.88) EPS for the quarter. The business had revenue of $0.65 million for the quarter. Nanovibronix had a negative net margin of 923.20% and a negative return on equity of 54.25%.

Insider Buying and Selling at Nanovibronix

In related news, insider Christian Michael Glibert sold 210,000 shares of Nanovibronix stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $0.69, for a total transaction of $144,900.00. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 1.40% of the company’s stock.

Analyst Upgrades and Downgrades

FEED has been the topic of a number of research analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of Nanovibronix in a research report on Friday, April 24th. Wall Street Zen upgraded shares of Nanovibronix from a “strong sell” rating to a “sell” rating in a report on Tuesday, April 28th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Nanovibronix presently has an average rating of “Sell”.

Nanovibronix Company Profile

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.